GlassScriptPhysician profile
Rahul Mishra
NPI 1487881124
$21,952.37
in general payments reported to CMS, 2019-2025
37 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,413 · 2020: $911 · 2021: $9,233 · 2022: $4,964 · 2023: $666 · 2024: $2,236 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,562 · Travel and Lodging: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,562.19 |
| Travel and Lodging | $869.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $10,831.53 | 2020-2022 | |
| Medtronic, INC. | $1,920.83 | 2021-2025 | Venaseal, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Medtronic USA, INC. | $1,215.25 | 2019-2020 | |
| Nevro Corp. | $1,127.25 | 2019-2021 | |
| Redhill Biopharma INC. | $915.85 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $798.10 | 2019-2025 | Xtampza |
| Forte Bio-Pharma LLC | $715.91 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Scilex Pharmaceuticals INC. | $506.12 | 2019-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $443.73 | 2019-2025 | Relistor |
| Pfizer INC. | $412.36 | 2019-2025 | |
| Zyla Life Sciences, INC. | $292.59 | 2019-2020 | |
| Abbvie INC. | $274.77 | 2021-2025 | |
| Epimed International, INC | $258.85 | 2019-2022 | |
| Daiichi Sankyo INC. | $258.78 | 2019 | |
| Abbott Laboratories | $244.33 | 2019-2024 | Proclaim |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.